Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers

✍ Scribed by Barbara White; Francisco Leon; Wendy White; Gabriel Robbie

• Book ID: 113543968
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 149 KB
• Volume: 31
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2009.04.019